Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

Resolution Therapeutics has treated the final patient in its Phase [...]

Circio has raised approximately NOK 200M (€18.6M) to advance its [...]

Circio and Full Circles Therapeutics are combining circular RNA and [...]

Andelyn Biosciences and Queen’s University have partnered to develop and [...]

MaxCyte has launched two sequencing-based assays to identify potential off-target [...]

VectorBuilder and Lir Therapeutics have entered a collaboration to optimise [...]

Researchers at Dongguk University in South Korea have developed an [...]

CellProthera and Alfresa Holdings have signed an MOU covering potential [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]